XENE (Xenon Pharmaceuticals) OCF Margin %: 0.00% (As of Mar. 2026)


XENE Xenon Pharmaceuticals Inc XENE
25 GF Score
Price $59.74
! 5 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals OCF Margin %?

Xenon Pharmaceuticals XENE +5.21% 25 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates XENE with a GF Score™ of 25/100. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Xenon Pharmaceuticals ranks worse than 89.05% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Xenon Pharmaceuticals's Cash Flow from Operations for the three months ended in Mar. 2026 was $-88.90 Mil. Xenon Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Xenon Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Xenon Pharmaceuticals's current OCF Yield % is -5.31%.

The historical rank and industry rank for Xenon Pharmaceuticals's OCF Margin % or its related term are showing as below:

XENE' s OCF Margin % Range Over the Past 10 Years
Min: -9236.66   Med: -1070.89   Max: -69.03
Current: -4084.84

During the past 13 years, the highest OCF Margin % of Xenon Pharmaceuticals was -69.03%. The lowest was -9236.66%. And the median was -1070.89%.

XENE's OCF Margin % is ranked worse than
89.05% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs XENE: -4084.84

Xenon Pharmaceuticals OCF Margin % Related Terms

Xenon Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Xenon Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xenon Pharmaceuticals OCF Margin % Chart

Xenon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -376.97 -1,070.89 0.00 0.00 -3,721.57

Xenon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -822.03 0.00 0.00 0.00 0.00

XENE vs CRSP, CGON, DNTH: OCF Margin % Comparison

For the Biotechnology subindustry, Xenon Pharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xenon Pharmaceuticals OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xenon Pharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Xenon Pharmaceuticals's OCF Margin % falls into.


XENE
25GF Score
Xenon Pharmaceuticals Inc XENE
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xenon Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Xenon Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-279.118/7.5
=-3,721.57 %

Xenon Pharmaceuticals's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-88.897/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Xenon Pharmaceuticals (XENE) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Xenon Pharmaceuticals and its competitors. According to the industry distribution chart, Xenon Pharmaceuticals ranks #854 out of 959 companies in the Biotechnology industry, placing it in the top 89.1%.
Is Xenon Pharmaceuticals' OCF Margin % too high?
Xenon Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Xenon Pharmaceuticals ranks #854 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Xenon Pharmaceuticals has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Xenon Pharmaceuticals' OCF Margin % compare to CRSP and CGON?
According to the Biotechnology industry distribution chart, Xenon Pharmaceuticals ranks #854 out of 959 companies for OCF Margin %. This places Xenon Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Xenon Pharmaceuticals and its competitors. Xenon Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xenon Pharmaceuticals stock overvalued right now?
Xenon Pharmaceuticals (XENE) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Xenon Pharmaceuticals' overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Xenon Pharmaceuticals (XENE), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xenon Pharmaceuticals Business Description

Other Exchanges XP0:Germany
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
25GF Score

Get the complete analysis for XENE

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$59.74
Price